ABTI - ALTEROLA BIOTECH INC.
0.001
0.000 -30.000%
Share volume: 154,435
Last Updated: 04-23-2025
Pharmaceutical Products/Medicinal Chemicals:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
-0.23%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q1 2024 | Q2 2024 | Q4 2024 | Q1 2025 | Q2 2025 | |
| Report Date | 07-17-2024 | 11-25-2024 | 11-21-2023 | 11-28-2024 | 11-25-2024 | 11-28-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||||
| Operating expenses | 180.258 K | 11.582 K | 25.539 K | 236.809 K | 64.890 K | 54.735 K | |
| Selling general and admin | 39.539 K | 11.582 K | 25.539 K | 210.919 K | 45.755 K | 37.771 K | |
| Research and development | 140.719 K | 0.000 | 0.000 | 25.890 K | 19.135 K | 16.964 K | |
| Total expenses | 208.854 K | 1.170 M | 74.995 K | 295.544 K | 682.822 K | 477.231 K | |
| 460.39% | -93.59% | 294.08% | 131.04% | -30.11% | |||
| Operating income | -208.854 K | -585.200 K | -123.157 K | -295.546 K | -682.822 K | -477.231 K | |
| Ebit | -247.156 K | -447.037 K | -123.157 K | 227.622 K | -654.747 K | -461.996 K | |
| Pretax income | -247.156 K | -447.037 K | -412.292 K | -326.519 K | -654.747 K | -799.193 K | |
| 80.87% | -7.77% | -20.80% | 100.52% | 22.06% | |||
| Income tax | -89.637 K | 0.000 | 0.000 | 194.800 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -348.456 K | -894.074 K | -412.292 K | 477.931 K | -1.309 M | -799.193 K | |
| -156.58% | 53.89% | 215.92% | -373.99% | 38.97% |
